Concepedia

Author

Yoshiaki Sonoda

Kyoto Prefectural University of MedicineORCID

Also Known As

Y Sonoda, Y. Sonoda, YOSHIAKI SONODA, Yoshiaki SONODA, Yoshiaki Sonoda, Yoshiaki Sonoda, M.D.

136

Publications

2.6K

Citations

27

H-Index

51

Concepts

All Affiliations

Kyoto Prefectural University of MedicineKansai Medical UniversityShiga University of Medical ScienceKyoto first Red Cross hospitalFukuda Denshi (Japan)
YS

About

Yoshiaki Sonoda is an author at Kyoto Prefectural University of Medicine specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

19

804

2

Cell Biology

14

18

786

3

Health Sciences

5

5

201

4

Biomedical Engineering

4

4

145

5

Engineering

2

2

57

Yoshiaki Sonoda

×

46

Publications

2.4K

Citations

27

H-Index

YearCitations

Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

Kazushi Inoue, Hiroyasu Ogawa, Yoshiaki Sonoda,

Blood

1997

368

Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Yoshiaki Sonoda, Y C Yang, GG Wong,

Proceedings of the National Academy of Sciences

1988

234

SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection

Jean Wang, Takashi Kimura, Ryuta Asada,

Blood

2003

204

Very low frequencies of human normal CD34<sup>+</sup> haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

Naoki Hosen, Yoshiaki Sonoda, Yusuke Oji,

British Journal of Haematology

2002

117

Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.

Yoshiaki Sonoda, Norie Arai, M Ogawa

PubMed

1989

90

Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand

Yoshikazu Ohmizono, H Sakabe, Takafumi Kimura,

Leukemia

1997

78

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells

Masaya Takahashi, Yoshikazu Matsuoka, Keisuke Sumide,

Leukemia

2013

71

5-Aza-2′-deoxycytidine treatment induces skeletal myogenic differentiation of mouse dental pulp stem cells

Ryusuke Nakatsuka, Tadashige Nozaki, Yasushi Uemura,

Archives of Oral Biology

2010

68

Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: The significance of the intra-bone marrow injection

Yoshiaki Sonoda

Journal of Autoimmunity

2008

62

Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.

Takafumi Kimura, Hideaki Sakabe, Shigeatsu Tanimukai,

PubMed

1997

62

Page 1